When Low Bone Mineral Density and Fractures Is Not Osteoporosis

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Current Osteoporosis Reports

• Publication date

  2019-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11914-019-00529-7PMID 31468499PMCID PMC6819255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fanconi Syndrome.

  2019cited by this paper
• Phosphate homeostasis disorders.

  2018cited by this paper
• Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.

  2018cited by this paper
• Bone histomorphometry in the evaluation of osteomalacia☆

  2018cited by this paper
• Phosphate wasting disorders in adults

  2018cited by this paper
• Actual reason for bone fractures in the case of a patient followed-up with the osteogenesis imperfecta: Gaucher's Disease.

  2017cited by this paper
• Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease

  2017cited by this paper
• Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

  2017cited by this paper
• Tumor-induced osteomalacia

  2017cited by this paper
• Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow

  2017cited by this paper
• Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets

  2017cited by this paper
• Hypophosphatasia: An overview For 2017.

  2017cited by this paper
• Bone Health in Patients With Hematopoietic Disorders of Bone Marrow Origin: Systematic Review and Meta‐ Analysis

  2017cited by this paper
• Spontaneous Growth and Effect of Early Therapy with Calcitriol and Phosphate in X-linked Hypophosphatemic Rickets.

  2017cited by this paper
• Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia‐like Bone Phenotype

  2017influential reference
• Zoledronate as effective treatment for minimal trauma fractures in a child with STAT3 deficiency and osteonecrosis of the hip

  2016cited by this paper
• Hip Fracture in Patients With Non‐Dialysis‐Requiring Chronic Kidney Disease

  2016cited by this paper
• Osteogenesis imperfecta

  2016cited by this paper
• Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.

  2016cited by this paper
• Low bone mineral density is a common finding in patients with homocystinuria.

  2016cited by this paper
• Bone involvement in adult patients affected with Ehlers-Danlos syndrome.

  2016cited by this paper
• Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

  2016cited by this paper
• Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment

  2016cited by this paper
• 68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.

  2016cited by this paper
• Predictors of Abnormal Bone Mass Density in Adult Patients with Homozygous Sickle-Cell Disease

  2015cited by this paper
• Factors associated with low bone mineral density in patients with cystic fibrosis

  2015cited by this paper
• Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia

  2015cited by this paper
• Muscle and Bone Impairment in Children With Marfan Syndrome: Correlation With Age and FBN1 Genotype

  2015cited by this paper
• Osteogenesis imperfecta in adults.

  2014cited by this paper
• Bone Density and Fractures in Autosomal Dominant Hyper IgE Syndrome

  2014cited by this paper
• Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis

  2014cited by this paper
• Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

  2014cited by this paper
• Evaluation of Teriparatide for Treatment of Osteoporosis in Four Patients with Cystic Fibrosis: A Case Series

  2014cited by this paper
• Rickets.

  2014cited by this paper
• Impairment of Bone Health in Pediatric Patients with Hemolytic Anemia

  2014cited by this paper
• Decreased bone mineral density in Costello syndrome.

  2014cited by this paper
• Loeys-Dietz syndrome.

  2014cited by this paper
• Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation

  2013cited by this paper
• Bone densitometry in patients with osteomalacia: is it valuable?

  2013cited by this paper
• Increased fracture risk and low bone mineral density in patients with loeys–dietz syndrome

  2013cited by this paper
• Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency

  2013cited by this paper
• Reduced Bone Density in Patients with Autosomal Dominant Hyper-IgE Syndrome

  2013cited by this paper
• Bone mineral density, growth, pubertal development and other parameters in Brazilian children and young adults with sickle cell anaemia

  2013cited by this paper
• Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?

  2012cited by this paper
• Mechanism of FGF23 processing in fibrous dysplasia

  2012cited by this paper
• Enzyme-replacement therapy in life-threatening hypophosphatasia.

  2012cited by this paper
• Osteogenesis imperfecta

  2012cited by this paper
• A clinician's guide to X‐linked hypophosphatemia

  2011cited by this paper
• The expanding family of hypophosphatemic syndromes

  2011cited by this paper
• Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients

  2011cited by this paper
• Loeys-Dietz syndrome

  2011cited by this paper
• Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.

  2011cited by this paper
• Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.

  2010cited by this paper
• Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.

  2010cited by this paper
• The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis

  2009cited by this paper
• Hypophosphatemia: the common denominator of all rickets

  2009cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.

  2009cited by this paper
• A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism

  2008cited by this paper
• A reference standard for the description of osteoporosis.

  2008cited by this paper
• Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)

  2008cited by this paper
• Bone mass density in adults with sickle cell disease

  2007cited by this paper
• Bone mineral density in children and adolescents with neurofibromatosis type 1.

  2007cited by this paper
• Bone mineral density in Marfan syndrome. A large case-control study.

  2006cited by this paper
• SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.

  2006cited by this paper
• Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

  2006cited by this paper
• Changes in bone mineral density following treatment of osteomalacia.

  2006cited by this paper
• Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.

  2006cited by this paper
• Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation.

  2005cited by this paper
• Decreased bone mineral density in patients with neurofibromatosis 1

  2005cited by this paper
• Bone involvement in sickle cell disease

  2005cited by this paper
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

  2003cited by this paper
• Cystic fibrosis

  2003cited by this paper
• Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria

  2002cited by this paper
• Renal Phosphate Wasting in Fibrous Dysplasia of Bone Is Part of a Generalized Renal Tubular Dysfunction Similar to That Seen in Tumor‐Induced Osteomalacia

  2001cited by this paper
• Gaucher's disease.

  2001cited by this paper
• Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption.

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

  2000cited by this paper
• Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.

  2000cited by this paper
• A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

  1995cited by this paper
• Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features *

  1995cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report

  1994cited by this paper
• Bone mineral content and density in healthy subjects and in osteogenesis imperfecta.

  1994cited by this paper
• DEXA Bone Densitometry Measurements in Adults with X‐linked Hypophosphatemia

  1993cited by this paper
• Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia.

  1992cited by this paper
• DECREASED BONE MINERAL DENSITY IN PATIENTS

  1988cited by this paper
• Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome.

  1988cited by this paper
• [Fanconi syndrome].

  1968cited by this paper
• Osteogenesis Imperfecta.

  year unknowncited by this paper

• Perfluorooctanoic acid and its alternatives disrupt the osteogenesis and osteoclastogenesis balance: Evidence from the effects on cell differentiation process.

  2025cites this paper
• Exposure to 6-PPD Quinone suppresses the proliferation and differentiation of osteoblasts by Nr4a1-p38 MAPK signal axis

  2025cites this paper
• Early Postmenopausal Fragility Fractures and Elevated IgE: Two Cases Suggesting Hyper-IgE Syndrome and a Novel Adverse Reaction to Romosozumab

  2025cites this paper
• Fracture Risk in Chronic Kidney Disease: Addressing an Overlooked Complication

  2025cites this paper
• Role of preoperative Hounsfield units in predicting subsidence after anterior cervical discectomy and fusion in the United States: a retrospective analysis including osteopenia diagnosis

  2025cites this paper
• Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies

  2025cites this paper
• Bone mineral density and body composition in Australians following plant-based diets vs. regular meat diets

  2024cites this paper
• Long-term second-generation antipsychotics decreases bone formation and resorption in male patients with schizophrenia

  2024cites this paper
• Low Bone Mineral Density on Computed Tomography: Association with Poor Survival after Transcatheter Aortic Valve Replacement

  2024cites this paper
• A Systematic Review on Osteoporosis Prediction in Postmenopausal Women

  2024cites this paper
• Matrix first, minerals later: fine-tuned dietary phosphate increases bone formation in zebrafish

  2024cites this paper
• Rickets, resorption and revolution: An investigation into the relationship between vitamin D deficiency in childhood and osteoporosis in adulthood in an 18th-19th century population.

  2024cites this paper
• Osteoporosis in adults in clinical practice (1): diagnosis and differential diagnosis.

  2023cites this paper
• Team Approach: Bone Health Optimization in Orthopaedic Surgery

  2023cites this paper
• MRI Quantification of Cortical Bone Porosity, Mineralization, and Morphologic Structure in Postmenopausal Osteoporosis.

  2023cites this paper
• Evaluating Patients for Secondary Causes of Osteoporosis

  2022cites this paper
• Weight change and fracture risk in patients with diabetic kidney disease: A nationwide population-based study

  2022influential citation
• Tenofovir-induced osteomalacia with hypophosphataemia

  2021cites this paper
• Response of the ENPP1‐Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice

  2021influential citation
• Systemic therapy of MSCs in bone regeneration: a systematic review and meta-analysis

  2021cites this paper
• Factors influencing peak bone mass gain

  2020cites this paper
• ORIGINAL INVESTIGATION

  year unknowncites this paper